Overview

Colon Neoadjuvant FOLFOXIRI Study

Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Objective tumour response rate to FOLFOXIRI to pre-operative therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Chinese University of Hong Kong
Treatments:
Capecitabine